相似文献
1
Periostin in vitreoretinal diseases.
Cell Mol Life Sci. 2017 Dec;74(23):4329-4337. doi: 10.1007/s00018-017-2651-5. Epub 2017 Sep 14.
2
Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy.
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5670-8. doi: 10.1167/iovs.10-6625.
3
[Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
Nippon Ganka Gakkai Zasshi. 2015 Nov;119(11):772-80.
4
Periostin in Eye Diseases.
Adv Exp Med Biol. 2019;1132:113-124. doi: 10.1007/978-981-13-6657-4_12.
5
Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
Br J Ophthalmol. 2015 May;99(5):629-34. doi: 10.1136/bjophthalmol-2014-305860. Epub 2014 Oct 29.
6
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
Gene Ther. 2015 Feb;22(2):127-37. doi: 10.1038/gt.2014.112. Epub 2014 Dec 11.
7
Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
Br J Ophthalmol. 2015 Apr;99(4):451-6. doi: 10.1136/bjophthalmol-2014-305321. Epub 2014 Oct 3.
8
Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.
Cell Mol Life Sci. 2022 Dec 31;80(1):22. doi: 10.1007/s00018-022-04670-y.
9
Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy.
FASEB J. 2014 Jan;28(1):131-42. doi: 10.1096/fj.13-229740. Epub 2013 Sep 10.
10
Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
Mol Vis. 2020 Jun 26;26:472-482. eCollection 2020.
引用本文的文献
1
Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
Int J Mol Sci. 2023 Feb 24;24(5):4509. doi: 10.3390/ijms24054509.
2
Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases.
Front Immunol. 2023 Feb 16;14:1107295. doi: 10.3389/fimmu.2023.1107295. eCollection 2023.
3
The Multiple Roles of Periostin in Non-Neoplastic Disease.
Cells. 2022 Dec 22;12(1):50. doi: 10.3390/cells12010050.
4
Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.
Cell Mol Life Sci. 2022 Dec 31;80(1):22. doi: 10.1007/s00018-022-04670-y.
5
Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy.
Pharmaceutics. 2022 Dec 8;14(12):2751. doi: 10.3390/pharmaceutics14122751.
6
The integrated transcriptome bioinformatics analysis identifies key genes and cellular components for proliferative diabetic retinopathy.
PLoS One. 2022 Nov 21;17(11):e0277952. doi: 10.1371/journal.pone.0277952. eCollection 2022.
7
Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine.
Cells. 2022 Aug 15;11(16):2531. doi: 10.3390/cells11162531.
8
Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.
Transl Vis Sci Technol. 2020 Feb 21;9(3):23. doi: 10.1167/tvst.9.3.23.
9
Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ.
Int J Ophthalmol. 2019 Feb 18;12(2):212-218. doi: 10.18240/ijo.2019.02.05. eCollection 2019.
本文引用的文献
1
Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization.
Mol Ther Nucleic Acids. 2017 Mar 17;6:279-289. doi: 10.1016/j.omtn.2017.01.004. Epub 2017 Feb 9.
2
Different roles played by periostin splice variants in retinal neovascularization.
Exp Eye Res. 2016 Dec;153:133-140. doi: 10.1016/j.exer.2016.10.012. Epub 2016 Oct 12.
3
Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV.
Lab Invest. 2016 Nov;96(11):1178-1188. doi: 10.1038/labinvest.2016.99. Epub 2016 Sep 26.
4
Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Mol Vis. 2016 Apr 30;22:436-45. eCollection 2016.
5
Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model.
Mol Ther Nucleic Acids. 2015 Oct 20;4(10):e258. doi: 10.1038/mtna.2015.34.
6
M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4767-77. doi: 10.1167/iovs.14-16012.
7
Reduced vitreal concentration of periostin after vitrectomy in patients with proliferative diabetic retinopathy.
Acta Ophthalmol. 2016 Feb;94(1):e81-2. doi: 10.1111/aos.12752. Epub 2015 May 14.
8
Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
Br J Ophthalmol. 2015 Jul;99(7):960-6. doi: 10.1136/bjophthalmol-2014-306366. Epub 2015 Jan 28.
9
Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy.
Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):932-46. doi: 10.1167/iovs.14-15589.
10
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
Gene Ther. 2015 Feb;22(2):127-37. doi: 10.1038/gt.2014.112. Epub 2014 Dec 11.
Zotero 插件